Dr. Furukawa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Drive, Lane L134
MC 5107
Stanford, CA 94305- Is this information wrong?
Education & Training
- Ronald Reagan UCLA Medical CenterPost-Doctoral Fellowship, NRSA T32 Primary Care Research Fellowship, 2019 - 2021
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 2018 - 2021
- UCLAMS, Health Policy and Management, 2019 - 2020
- Cedars-Sinai Medical CenterResidency, Internal Medicine, 2015 - 2018
- David Geffen School of Medicine at UCLAClass of 2015
Certifications & Licensure
- CA State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsState-of-the-Art Review: Use of Antimicrobials at the End of Life.Daniel Karlin, Christine Pham, Daisuke Furukawa, Ishminder Kaur, Emily Martin, Olivia Kates, Tara Vijayan> ;Clinical Infectious Diseases. 2024 Mar 20
- Executive Summary: State-of-the-Art Review: Use of Antimicrobials at the End of Life.Daniel Karlin, Christine Pham, Daisuke Furukawa, Ishminder Kaur, Emily Martin, Olivia Kates, Tara Vijayan> ;Clinical Infectious Diseases. 2024 Mar 20
- No differences in outcomes with stopping or continuing antibiotic suppression in periprosthetic joint infections.Megan Dunning, Sa Shen, Daisuke Furukawa, Amy Chang, Jenny Aronson, Derek F Amanatullah, Gina A Suh, Shanthi Kappagoda> ;Journal of Bone and Joint Infection. 2024 Jan 1
- Join now to see all
Journal Articles
- A Case of Fever of Unknown Origin Following Cardiac Arrest With Diagnosis Revealed on AutopsyDaisuke Furukawa, Owen McBride, Casey Kaneshiro, Jaime Betancourt, Infectious Diseases in Clinical Practice, 9/2018
- No to Pip-Tazo Identifying Inappropriate Use of Piperacillin-Tazobactam for Treatment of Skin and Soft Tissue InfectionsDaisuke Furukawa, Christopher Graber, Infectious Diseases in Clinical Practice, 7/2017
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: